Silencing of GLS1 or impairing glutamine metabolism were able to counteract the induction of EMT mediated by growth factors (e.g., TGF-β) in breast and colon cancers by increasing Snail1-targeting miRNA expression and hence impacting on Snail stability (Figure 2). This evidence concerns the gene SNAI1 and malignant colon neoplasm.